Modulation of NMDA and AMPA/kainate receptors by tocotrienol-rich fraction and α-tocopherol in glutamate- induced injury of primary astrocytes by Abedi, Zahra
 
 
UNIVERSITI PUTRA MALAYSIA 
 
MODULATION OF NMDA AND AMPA/KAINATE RECEPTORS BY 
TOCOTRIENOL-RICH FRACTION AND α-TOCOPHEROL IN 








MODULATION OF NMDA AND AMPA/KAINATE RECEPTORS BY 
TOCOTRIENOL-RICH FRACTION AND α-TOCOPHEROL IN
GLUTAMATE- INDUCED INJURY OF PRIMARY ASTROCYTES 
By
ZAHRA ABEDI 
Thesis Submitted to the School of Graduate Studies, Universiti Putra Malaysia, 








All material contained within the thesis, including without limitation text, logos, 
icons, photographs and all other artwork, is copyright material of Universiti Putra 
Malaysia unless otherwise stated. Use may be made of any material contained within 
the thesis for non-commercial purposes from the copyright holder. Commercial use of 
material may only be made with the express, prior, written permission of Universiti 
Putra Malaysia.






Abstract of thesis presented to the Senate of Universiti Putra Malaysia in fulfilment of 
the requirement for the degree of Master of Science 
MODULATION OF NMDA & AMPA/KAINATE RECEPTORS BY 
TOCOTRIENOL-RICH FRACTION AND α-TOCOPHEROL 




Chairman :  Huzwah Binti Khaza’ai, PhD
Faculty :  Medicine and Health Sciences 
Neurodegenerative diseases such as Huntington`s, Alzheimer`s, Parkinson’s disease 
and stroke are the most common diseases suffered by the aged population. Glutamate 
is considered as a main excitatory amino acid neurotransmitter in the mammalian 
central nervous system which can be excitotoxic, playing a key role in series of 
chronic neurodegenerative diseases. The Vitamin E which consist of tocopherol and 
tocotrienols, are different in their side chain either in saturated or unsaturated phytyl 
tail. Previous studies have demonstrated that tocopherol and tocotrienol have 
protective effects against glutamate toxicity in an astrocytic cell line.  The aim of 
current study is to demonstrate the potential of tocopherol and tocotrienol in 
protecting glutamate injured primary astrocytes. For this purpose, the primary 
astrocytes were isolated from mixed glial cells of C57BL/6 mice by using the Easysep
Mouse CD11b positive selection kit and cultured in supplemented DMEM. Mixed 
glial cultures were treated with 50-75 mM L-leucine methyl ester (LME) for 60-90 
minutes to improve purity of cultures. The purity of primary astrocytes was measured 
by flow-cytometer and is approximately 79.4%. The   IC20 and IC50 values of 
glutamate were determined by MTT assay at 10 mM and 100 mM respectively. Cell 
were induced injury at IC20 and IC50 of glutamate and the effects of tocopherol and 
tocotrienol rich fraction (TRF) was determined.in pre and post-treatment study.  For 
the high yield of RNA, the IC20 of glutamate was used in the experiment. Exposure to 
100 mM of glutamate in primary astrocytes reduced cell viability by approximately 
64.75 % and 61.10 % in pre and post treatment study respectively. The mitochondrial 
membrane potential (MMP) detected in primary astrocytes were assessed with 100, 
200 and 300 ng/ml concentration of TRF and α-Tocopherol. The results depicted that 
pre-treatment with TRF and α-Tocopherol caused the mitochondrial activity to 
achieve 88.46%, 82.42%, 80.74% and 93.31%, 87.51%, 83.70%, respectively. In 
post-treatment study, with increase of TRF (100, 200 and 300 ng/ml) concentration 
causes the increase to 61.21%, 73.01%, 78.43% of MMP value. Similarly, increase of






concentration of α-Tocopherol. Then the expression of ionotropic glutamate receptors 
genes was elucidated using Real-time PCR. The gene of interest consists of the Gria2 
(Glutamate Receptor, Inotoropic AMPA), GRIK1 (Glutamate Receptor, Ionotropic, 
kainate1) and Grin2A (Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2A). 
The results showed that in both pre and post studies, the ionotropic glutamate 
receptors genes were down regulated after the treatment and α- tocopherol played an 
important role in down regulating the genes. The most affected genes were Gria2, 
GriK1 and Grin2A respectively in both pre and post studies. Decreased intracellular 
calcium concentration also was observed indicating the present of vitamin E altered 
the polarization of astrocytes. As a conclusion, this study shown that α- tocopherol is 
more effective and only required low concentration of α- tocopherol for prophylactic 
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Penyakit neurodegeneratif seperti Huntington’s, Alzheimer’s dan Parkinson’s dan 
strok adalah penyakit yang sering dialami oleh populasi golongan warga tua. 
Glutamate merupakan neurotransmiter utama asid amino bagi sistem saraf pusat 
mamalia yang boleh menyebabkan eksitotoksik dan ia memainkan peranan penting 
dalam siri penyakit kronik neurodegeratif. Vitamin E terdiri daripada tokoferol dan 
tokotrienol yang mempunyai perbezaan dari segi struktur rantai sisi lemak tidak tepu 
dan lemak tepu. Berdasarkan kajian sebelum ini, tokoferol dan tokotrienol didapati 
mempunyai kesan pelindung terhadap toksisiti glutamat di dalam sel astrosit. Tujuan 
kajian ini dilakukan adalah bagi melihat potensi Vitamin E dalam melindungi sel 
astrosit primer daripada kecederaan yang disebabkan oleh glutamate. Dengan ini, sel 
primer astrosit telah dipencilkan daripada campuran sel glial tikus C57BL/6 dengan 
menggunakan kit pemilihan positif  Easysep Mouse CD116 dan dikulturkan di dalam 
media DMEM yang mengandungi supplemen. Kultur campuran glial dirawat selama 
60-90 minit dengan 50-75 mM L-leucine methyl ester (LME) bagi tujuan 
memperbaiki ketulenan kultur tersebut. Ketulenan sel astrosit yang diperolehi adalah 
79.4% dengan menggunakan “flow-sitometer”. Nilai IC20 dan IC50 glutamate 
ditentukan dengan menggunakan MTT asai iaitu 10 mM dan 100 Mm. Sel 
dicederakan dengan glutamat pada aras IC20 dan IC50 untuk kesan tokoferol dan fraksi 
kaya tokotrienol (TRF) dan ditentukan di dalam pra dan pasca  rawatan. Bagi tujuan 
menghasilkan RNA yang tinggi, eksperimen dijalankan dengan menggunakan 
glutamat pada IC20. Pada kepekatan 100 mM glutamat di dalam sel astrosit utama 
menyebabkan pengurangan sel hidup dengan anggaran 64.75% dan 61.10% di dalam 
pra dan pasca rawatan. Potensi membran mitokondria (MMP) mengesan sel utama 
astrosit pada kepekatan 100, 200 dan 300 ng/ml untuk fraksi kaya tokotrienol (TRF) 
dan α-tokoferol. Hasil kajian pra-rawatan dengan menggunakan TRF dan α-tokoferol 
menyebabkan aktiviti mitokondria telah mencapai sebanyak 88.46%, 82.42%, 80.47%  






pula, pertambahan kepekatan TRF pada 100, 200 dan 300 ng/mL menyebabkan 
kenaikan nilai MMP kepada 61.21%, 73.01% dan 78.43%. Kenaikan yang serupa bagi 
nilai MMP daripada 66.12%, 76.46% ke 81.22% diperhatikan apabila kepekatan 
α-tokoferol meningkat. Ekspresi reseptor gen ionotropik glutamat juga telah 
dikenalpasti menggunakan “Real-time PCR”. Gen-gen tersebut ialah Gria2 (Reseptor 
gluatamate, Ionotropic AMPA), GRIK1 (Reseptor Glutamate, Ionotropik, Kinate 1) 
dan Grin2A (Reseptor Glutamate, Ionotropik, N-Methyl-D-Aspartate 2A). Kajian 
didapati, kedua-dua pra dan pasca rawatan menunjukkan reseptor ionotropik 
glutamate menurun selepas rawatan, dan ini menunjukkan keberkesanan α-tokoferol 
dalam mengawal selia gen-gen tersebut. Gen yang paling terkesan dalam pra dan 
paska rawatan kajian, adalah Gria2, Grik1 dan Grin2A.  Penurunan kepekatan kalsium 
pada intraselular menyebabkan perubahan polarisasi pada sel astrosit dengan 
kehadiran vitamin E. Kesimpulannya, kajian ini menunjukkan α-tokoferol adalah 
lebih berkesan dan memerlukan hanya kepekatan yang rendah bagi tujuan profilaktik 
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1.1 Background of the study 
Neurodegenerative diseases such as Alzheimer’s disease and Parkinson as well as 
stroke are some of the common diseases among the aged individuals. In 
neurodegenerative diseases in mammals, cell death occurs in the brain due to two 
reasons: either the accumulation of amyloid beta (AB) protein or oxidative glutamate 
toxicity that causes neuronal cell death (Murphy et al., 1990). 
The endogenous chemicals which transmit a signal from one neuron to another neuron 
across a synapse are referred to as neurotransmitters. These transmitters bind to a 
receptor in postsynaptic membrane where depolarization is caused by an excitatory 
neurotransmitter. In contrast, hyper-polarization in the postsynaptic membrane occurs 
as a result of an inhibitory neurotransmitter. It is assumed that glutamate, which is the 
main amino-acid neurotransmitter stimulant in the mammals’ central nervous system 
can be excitotoxic at higher concentration, which mainly responsible for 
neurodegenerative diseases. 
Glutamate which is considered as an important excitatory amino acid neurotransmitter 
plays a key role in the mammals’ central nervous system. It can be excitotoxic and is 
assumed to be a cause of most types of neurodegenerative diseases (Zou & Crews, 
2005). According to (Coyle & Puttfarcken, 1993), glutamate toxicity is a kind of 
brain-cell death which is associated with many types of chronic neurodegenerative 
diseases such as Alzheimer’s, Parkinson’s, and Huntington’s diseases.  
There are two reasons for the occurrence of glutamate toxicity: receptor-originated 
excitotoxicity and non-receptor mediated toxicity. In the former type, excitotoxicity is 
caused by the activation of glutamate receptors, while in the latter it is the result of a 
series of disturbances, which reduce and oxide homeostasis in the cells. There are two 
main types of glutamate receptors: ionotropic receptors that are ligand-gated ion 
channels and metabotropic receptors, which are coupled with second messenger 
systems by G proteins (Hollmann & Heinemann, 1994). Cell death caused by 
excitotoxicity is due to the lack of three functional families of ionotropic glutamate 
receptors known as N-Methyl-D- Aspartate (NMDA) receptor, 
α-Amino-3-Hydroxy-5-Methyl-4- isoxazolepropionic acid (AMPA) receptor and 
Kainate receptor. These receptors are considerably penetrable to Ca2+ ions as well as 
Na+ and K+. Thus, the increase in [Ca2+] through this receptor–gated channels is 







When a neuron and glial cell injury occur , as a result of their deprivation of oxygen 
and glucose, ATP decreases rapidly and becomes depolarized which leads to the 
release of glutamate from nerve terminals and eventually caused reduction of 
glutamate uptake by glial cells (SIESJÖ et al., 1995). 
Additionally, glutamate accumulation over-excites the post-synaptic NMDA and 
AMPA receptors leading to an intracellular overload of Ca2+ (Sattler & Tymianski, 
2001). Furthermore, increased of Ca2+  uptake into mitochondria due to strong 
loading, which can disrupt their function and lead to the release of damaging reactive 
oxygen species (ROS)(Dowling, 2001). Ca2+ loading may also lead to the generation 
of ROS through other mechanisms, such as the activation of nitric oxide synthetase 
(NOS), resulting in nitric oxide production, and the activation of NADPH-oxidase 
producing superoxide in mitochondria (Brennan et al., 2009). The generated ROS can 
induce DNA damage, which causes the activation of Poly ADP ribose polymerase 
(PARP) enzyme, capable of injuring neurons via NAD+ depletion, causing glycolytic 
block, ATP depletion, and induction of apoptotic signaling pathway through the 
release of apoptosis- inducing factor (AIF) from mitochondria (Alano et al., 2010).
In the case of a cerebral insult, the role of astrocytes in improving neuronal survival 
and recovery is increasingly recognized. The large body of recent studies on 
neuroprotection has focused on improving the neuron survival (Chang et al., 2009);
however, a main simultaneous effect of ischemic infarction is the death of glia, 
especially astrocytes.  
When an astrocyte is damaged, reduction of astrocytes function can lead to loss of 
CNS and the overall pathology related to the excitatory amino acids (Chen et al., 
2000). Thus, it is essential to identify the responsible mechanisms in astrocytes death 
after insults and it should result in developing strategies with the specific aim of 
promoting astrocytes survival. Many studies have shown astrocytes damage after 
neurodegenerative disorders (Landis, 1994; Liu et al., 1999). For example, a study by 
Chen (2000)(Chen et al., 2000) showed that stimulating astrocytes with glutamate 
cause cell swelling and cell death. 
With regard to the significance of the astrocyte survival in the occurrence of glutamate 
insult, it is highly desirable to find treatments to prevent excitotoxicity that causes cell 
death.  It has been shown that astrocytes treated with vitamin E were able to resist 
glutamate excitotoxicity (Chen et al., 2001).  The neuroprotective properties of 
Vitamin E composed of eight different isoforms, four tocopherols (α-,β-,γ-,δ-) and 
four tocotrienols (α-,β-,γ-,δ-) have been identified (Aggarwal et al., 2010). 
Structurally, tocopherols and tocotrienols are different, in which the former possesses 
a saturated phytyl tail, while the latter has an unsaturated isoprenoid side chain. Palm 
tocotrienol-rich fraction (TRF) which is extracted from palm oil contains 75% 
tocotrienols and 25% α-tocopherol. It was illustrated that TRF has potent antioxidant 
(Maniam et al., 2008; Serbinova & Packer, 1994), anti-inflammatory (Wu et al., 






neuroprotection (Osakada et al., 2004; Sen et al., 2000) and cholesterol-lowering 
effects(Minhajuddin et al., 2005; Mutalib et al., 2003; Qureshi et al., 1995).  
Most of the studies have focused on the neuronal cell protection rather than astrocytes
(Pettmann & Henderson, 1998; Wang et al., 2005). Hence, the present study attempts 
to investigate the effects of tocotrienols and tocopherols in preventing glutamate 
excitotoxicity in astrocytes. Besides promoting astrocytes survival, advanced 
neuroprotection would be expected. The prophylactic and preventive properties of 
tocotrienols and tocopherol in neurodegeneration are expected to be achieved and an 
alternative therapeutics based on nutrition would be offered. 
1.2 Research Problem 
Glutamate excitotoxicity in astrocytes cells leads to the release of Ca2+ and 
reactivation of free radicals by over-activation of glutamate receptors that eventually 
cause neuronal neurodegeneration and cell death. Controlling the receptor activity and 
inhibition of Ca2+ , release of glutamate and free radicals from astrocyte cells may be 
an effective method for preventing neurodegeneration. Does neuroprotective action of 
tocotrienol and tocopherols prevent astrocyte cells death induced glutamate?
1.3 Research Objectives 
1.3.1 General Objective 
To determine the role of tocotrienols and tocopherols in the prevention of glutamate 
toxicity in injured primary astrocytes.
1.3.2 Specific Objectives 
 To determine the IC20 and IC50 values of glutamate in primary astrocyte  
cells. 
 To determine the effect of tocotrienols and tocopherols on cell viability in 
primary astrocytes injured by glutamate.  
 To determine the effect of tocotrienols and tocopherols on NMDA 
receptors in primary astrocytes injured by glutamate.  
 To determine the  effect of  tocotrienol and tocopherols on the  activation of  
Ca2+permeabililty in AMPA/Kainate receptors in  primary astrocytes 
injured by glutamate. 
 To determine the effect of tocotrienol and tocopherols on Ca2+ ion influx  in 







Tocotrienols and tocopherols are capable of modulating glutamate receptors and Ca2+
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